| PERIOD ENDING | 27-Mar-09 | 28-Mar-08 | 30-Mar-07 | | Total Revenue | 65,788 | 116,144 | 84,094 | | Cost of Revenue | 55,248 | 57,290 | 39,070 | | | Gross Profit | 10,540 | 58,854 | 45,024 | | | Operating Expenses | | Research Development | 21,817 | 24,279 | 21,432 | | Selling General and Administrative | 34,281 | 31,551 | 31,828 | | Non Recurring | 36,620 | 175 | 10,183 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (82,178) | 2,849 | (18,419) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 32,604 | 5,459 | 3,558 | | Earnings Before Interest And Taxes | (49,574) | 8,308 | (14,861) | | Interest Expense | 3,862 | 2,847 | 1,841 | | Income Before Tax | (53,436) | 5,461 | (16,702) | | Income Tax Expense | 67 | (1,684) | (508) | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (53,503) | 7,145 | (16,194) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (53,503) | 7,145 | (16,194) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($53,503) | $7,145 | ($16,194) |
|
0.29% Nasdaq 
0.10 (2.50%) 
Income Statement
